# Tevogen Inc.: Form 8-K, filed Aug 23, 2024

- Company: [Tevogen Inc.](/companies/tvgn.md) (CIK 1860871)
- Form: 8-K
- Filed: 2024-08-23
- Accepted by EDGAR: Aug 23, 2024, 17:02 ET
- Period: 2024-08-20
- Accession: 0001493152-24-033756
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1860871/000149315224033756/form8-k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1860871/000149315224033756/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 3.02: Unregistered sale of equity
- Item 5.02: Departure or appointment of officers or directors
- Item 5.03: Amendment to articles or bylaws
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1860871/000149315224033756/form8-k.htm

Filed Aug 23, 2024.
Source: SEC EDGAR, the filing index for accession 0001493152-24-033756. Last ingested by Listed: Oct 24, 2026, 15:06 ET. No prices; not investment advice.